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Abstract
Ischemic heart disease is one of the leading causes of morbidity and death worldwide. Consequently, myocardial infarctions are
often encountered in clinical and forensic autopsies, and diagnosis can be challenging, especially in the absence of an acute
coronary occlusion. Precise histopathological identification and timing of myocardial infarction in humans often remains uncer-
tain while it can be of crucial importance, especially in a forensic setting when third person involvement or medical responsi-
bilities are in question. A proper post-mortem diagnosis requires not only up-to-date knowledge of the ischemic coronary and
myocardial pathology, but also a correct interpretation of such findings in relation to the clinical scenario of the deceased. For
these reasons, it is important for pathologists to be familiar with the different clinically defined types of myocardial infarction and
to discriminate myocardial infarction from other forms of myocardial injury. This article reviews present knowledge and post-
mortem diagnostic methods, including post-mortem imaging, to reveal the different types of myocardial injury and the clinical-
pathological correlations with currently defined types of myocardial infarction.
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Introduction
Acute ischemic heart syndromes, which are acute myocardial
infarction (MI), various types of unstable angina and sudden
coronary death, are the prevailing acute life-threatening dis-
eases with high mortality rates. They occur not only in the
Western World but also in industrialized developing countries
[1, 2]. Consequently, a diagnosis of MI or sudden coronary
death is often considered in situations of clinical or forensic
autopsy. Coronary artery disease (CAD), which underlies most
cases of MI, and also the ischemic myocardial pathology in
different stages of injury and repair have been studied exten-
sively to improve post-mortem diagnosis. Ancillary techniques
to visualize ischemic injury have been developed or are now
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under investigation for improvement [3–5]. Recent develop-
ments are non- (or minimally invasive) post-mortem imaging
techniques to detect coronary occlusion and ischemic injury in
order to serve as an adjunct to, or even to replace, cardiac
autopsy with presumed ischemic death [6, 7]. These novel
post-mortem approaches presently attract much interest; autop-
sy rates tend to decrease gradually in many countries [8].
However, in some situations, these diagnostic modali-
ties alone may prove inadequate or insufficient to explain
a clinical suspicion of myocardial ischemia. Examples are
the sudden coronary deaths without thrombus, the cases
of peri-procedural myocardial ischemia after therapeutic
coronary interventions (in which early myocardial ische-
mia cannot be detected yet) or the non-coronary causes of
ischemia. Finally, in some cases, also types of myocardial
injury other than ischemic should be considered. This is
reflected in the current clinical classification of MI, which
discriminates five types with differences in etiological
background, pathogenic mechanisms and evolving treat-
ment strategies [9].
In this article, we review the present knowledge and
post-mortem diagnostic methods to reveal MI at autopsy,
how it should be discriminated from other forms of myo-
cardial injury, and in particular, how pathology should be
interpreted in relation to currently defined clinical types of
MI.
Clinical diagnosis of MI
Clinical diagnosis of MI is based on the presence of ele-
vated cardiac troponin levels, in combination with
prolonged chest pain, ECG recordings or regional wall
motion abnormalities indicative of recent onset ischemia
or angiographic detection of a coronary thrombus. Based
on huge variety in the pathophysiology underlying MI, a
subdivision into five distinct subtypes has recently been
updated in the 4th universal definition of myocardial in-
farction document (2018) published by the Joint Task
Force of the European Society of Cardiology, the
American College of Cardiology Foundation, the
American Heart Association and the World Heart
Federation [9] (Table 1).
Type 1 MI is the result of acute coronary artery athero-
thrombosis. In clinical series, based on in vivo imaging
studies, thrombotic coronary events can be observed in
about 80% of patients with acute coronary syndromes
(ACS), although percentages may vary due to different
diagnostic modalities and differences in demographic fea-
tures of the patient groups involved. For therapeutic rea-
sons, it is important to further classify the type 1 infarc-
tions based on ECG findings as either ST elevation types
of MI (STEMI) or non-ST elevation types of MI (non-
STEMI).
Type 2 MI are infarctions that result from myocardial
oxygen supply-demand imbalance and are not due to
acute coronary plaque disruption and thrombosis. For ex-
ample, MI with angiographically normal or low-grade ste-
nosis (stenosis ≤50%) is a clinically well-recognized syn-
drome (called MI with non-obstructive coronary arteries,
MINOCA), caused by a variety of pathology in and out-
side the heart. MI type 2 includes also relatively rare non-
atherosclerotic coronary diseases such as spontaneous dis-
section or embolization. Nevertheless, it should be noted
that stable (not thrombosed) coronary plaques are com-
monly present in patients with type 2 MI. Diseases that
may cause or at least contribute to oxygen supply-demand
mismatch leading to myocardial injury are listed in
Table 2. Altogether, reported frequencies of type 2 MI
vary from 10 to 30% of all MI patients.
Patients who present with clinical symptoms that are highly
suspicious of MI in combination with new ECG changes or are
in ventricular fibrillation (VF), but who die before cardiac bio-
markers of ischemia can be identified, are designated as type 3
MI. They have reported frequency of 3–4% of all MI [10].
MI diagnosed by a significant rise of biomarkers related to
percutaneous coronary revascularization procedures are designat-
ed as type 4 MI. They can be temporally related to the procedure
(within 48 h) leading to critical myocardial flow reduction, but
may also be due to acute complications of a device such as in-
stent thrombosis, coronary dissection or the late stent complica-
tions such as restenosis and late onset thrombosis.
Similarly, type 5 MI is due to ischemic injury associated with
coronary artery bypass grafting (CABG) within 48 h of the pro-
cedure. It can be procedure-related, or related to low-flow, poor
run-off or reperfusion damage.
Table 1 ESC/AHA/ACC/WHF classification of MI 2018 [9]
Type 1 Acute atherothrombotic occlusion or mural thrombus with critical flow reduction initiated by plaque rupture or erosion
Type 2 Ischemic injury due to a myocardial oxygen supply-demand mismatch, which is not caused by coronary atherothrombosis (Table 2)
Type 3 Cardiac death in a clinical setting suggestive of ischemic injury (chest pain, ECG changes) but without definitive cardiac biomarker evidence
Type 4 PCI-related ischemic injury < 48 h after procedure. Includes also cases of MI due to late stent thrombosis or restenosis
Type 5 CABG-related ischemic injury < 48 h after the procedure
ESC, European Society of Cardiology; AHA, American Heart Association; ACC, American college of Cardiology; WHF, World Heart Federation
Virchows Arch
Ischemia and other forms of myocardial injury
In clinical guidelines, a distinction is made between myocar-
dial injury, which encompasses any form of acute myocardial
damage or destruction, and MI, resulting from myocardial
ischemia only [9]. Evidently, MI is a form of myocardial in-
jury, and both entities share the presence of raised serum levels
of cardiac troponin (cTn) in a patient. In order to discriminate
clinically a MI from other types of myocardial injury, addi-
tional criteria such as angina symptoms and characteristic
ECG changes are needed.Most important other forms of myo-
cardial injury are listed in Table 3 and should be considered by
pathologists at autopsy in the differential diagnosis of MI. For
example, differential diagnosis of myocarditis is not always
presented by clinical settings and this differentiation may arise
from pathological standpoint [11].
Anatomical substrates of myocardial
infarction at autopsy
Coronary artery pathology
Acute obstruction and critical stenosis
The most frequent cause of acute myocardial ischemia is
atherothrombotic occlusion of a coronary artery [3, 12]. The
presence of a mural or totally occlusive thrombotic mass can
be observed at autopsy in approximately 50–70% of sudden
coronary deaths and is a reliable marker of myocardial ischemia,
even in absence ofmicroscopically visible necrosis [12, 13]. This
implies that in cases of sudden death, acute coronary occlusion
can explain arrhythmic death [3].
The underlying pathology of mural or occlusive coronary
thrombosis is variable and can be due to plaque ruptures, ero-
sions or, less frequently, protruding calcified nodules. Also,
intraplaque haemorrhages contribute to the acute flow reduction
in these instances [14–16]. It is important to note that there can be
a considerable time interval between the onset of plaque disrup-
tion and the evolving critical stenosis or occlusion by thrombus.
And also the onset of necrosis in the heart and the clinical man-
ifestation of symptoms of MI are not always around the same
time [17, 18]. It is not rare to find even organized thrombi or
significant myocardial necrosis at autopsy in a patient with acute
onset of ischemic symptoms [18, 19].
At autopsy, the main coronary arteries and large branches
such as diagonal and obtuse marginal are examined by trans-
versely sectioning at 3-mm intervals to identify thrombus and
critical stenosis. For reliable interpretation, heavily calcified
arteries are decalcified prior to cross sectioning. The most
severely affected sections can be sampled for histology [3].
Stenosis due to stable (not thrombosed) plaques
The first assessment of luminal stenosis made by the eye is
moderately consistent and accurate measure at low (< 30–
Table 3 Most frequent causes of
myocardial injury, other than
myocardial ischemia
Myocarditis Toxic, immune mediated, infectious
Cardiomyopathies Adrenergic, RAAS, cytokine and mechanical stress
Radiation-induced injury Various mechanisms of myocardial cell death
Drugs May cause ischemic injury or other types of injury
Endogenous catecholamines Takotsubo, stress, extreme exercise
Cardiac interventions Cardiac surgery, PCI, TAVI, ablation procedures
Trauma Cardiac contusion, CPR-related tissue damage
Sepsis Extreme cytokine release
Cerebrovascular accidents Catecholamines and (neuro)inflammatory response
Chronic kidney disease Mechanical stress, toxic uraemic
After cardiac transplantation Myocardial immune injury (cellular and humoral rejection)
Table 2 Causes of MI without atherothrombotic coronary artery disease
Fixed coronary atherosclerotic plaques In combination with non-coronary causes of oxygen
demand-supply imbalance
Non-atherosclerotic coronary artery disease Spasm/SVD, vasculitis, dissection, embolism, congenital anomalies,
fibromuscular dysplasia, iatrogenic (stent or graft restenosis),
PCI-related no-reflow
Non-coronary cardiac oxygen demand-supply imbalance Sustained tachyarrhythmias, bradyarrhythmias,
LV hypertrophy and/or dilatation
Extra cardiac oxygen demand-supply imbalance Respiratory failure, severe anaemia, hypovolemic shock
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50%) and high (> 70–75%) grade stenosis. Accuracy can be
improved by a visual aid, similar to that in Fig. 1 [20]. Ideally,
gross assessments should be confirmed by histology, taking
the internal elastic lamina as the original lumen size. This
approach has a good inter-observer reproducibility in high-
degree lesions [21]. However, lumen shape may affect the
interpretation of stenosis, with pathologists overestimating
the stenosis caused by slit-like lumens, and underestimating
concentric and eccentric stenosis [22]. Geometric remodelling
of the artery contributes importantly to the rate of lumen ste-
nosis. Arteries are dynamic organs, in which compensatory
expansive enlargement in association with unstable plaques
and constrictive shrinkage in stable collagen-rich plaques is
known as positive and negative remodelling respectively [23].
In case of a fixed stenotic stable plaque of > 75% stenosis,
concomitant functional alterations such as exercise or spasm
can evoke irreversible myocardial injury. Therefore, a stenosis
of 75% or more is considered as critical [24, 25]. Stenosis of
90% or more leaves myocardium ischemic even at rest and
can be seen as a ‘pinpoint’ lumen less than 1 mm in diameter.
Many of these stenoses have stable tissue composition of fi-
brous tissue and calcifications but without thrombus [25]. In
these instances, microscopy of malperfused territories of the
myocardium can be a helpful adjunct in diagnosis. Clinically,
these infarctions are diagnosed as type 2 MI. However, in
some cases, mural thrombus can be identified histologically,
which implies a reclassification to type 1 MI. The evidence
described so far relates to atherosclerotic CAD. Other condi-
tions that may cause coronary stenosis are listed in the differ-
ential diagnosis of type 2 MI (Table 2).
Coronary spasm
Coronary artery spasm (CAS) is defined as an intense con-
striction of the vascular wall, which causes total or subtotal
occlusion of the coronary arteries. Clinically, spasm is one of
the MINOCAs, grouped under type 2 MI. The presence of an
area of regional infarction in the myocardium could point
towards spasm in the artery when no other explanation for
the infarction is provided. It can affect either the epicardial
arteries, as initially proposed by Prinzmetal et al. ([26] or the
microcirculation, or both. The most frequent pathologic sub-
strate of CAS is atherosclerotic CAD, but it has also rarely
been reported in normal vessels [27]. Imaging tools such as
computerized tomographic angiography (CTA), intravascular
ultrasound (IVUS) and optical coherence tomography (OCT)
show that the coronary artery segments where spasm is induc-
ible are typically characterized by diffuse intimal and medial
thickening with low lipid or calcium content, negative remod-
elling and small luminal area [28, 29]. These features are in
line with the hypothesis that vascular smooth muscle cell
hyper-reactivity is a pathophysiological substrate for spasm
[30]. Spasm and plaques are certainly not mutually exclusive
features; spasms have been documented distal to stable
plaques, in plaque-free segments bordering large eccentric
plaques, and may serve as a ‘rupture trigger’ by inducing a
plaque rupture followed by thrombosis in ‘high-risk’ plaques.
Clinically, the combination of severe CAD and spasm is as-
sociated with adverse prognosis [31]. At autopsy, there are no
distinctive gross or histologic hallmarks of CAS; thus, the
possible morphologic substrates associated with an increased
risk of spasm must be searched for, as well as microscopic
evidence of ischemia. Drugs (cocaine, amphetamine and de-
rivatives, androgenic anabolic steroids, chemotherapy), phys-
ical and mental stress and release of vasoconstrictor agents by
activated platelets (mural thrombus) are considered precipitat-
ing factors of spasm [32–35]. Very rarely, CAS can occur in
the setting of allergic/hypersensitivity reactions, which is
known as Kounis Syndrome and histologically characterized
by presence of eosinophils [36].
Small vessel diseases
Small vessel diseases (SVD) can occur without obvious struc-
tural changes of the heart.Microvascular dysfunction (MVD) is
a functional impairment of pressure and flow in intramyocardial
Fig. 1 Coronary artery segments
with different degrees of
atherosclerotic stenosis. The
diagrams demonstrate a 50% area
stenosis, 75% stenosis and 90%
stenosis; diameter x will usually
be less than 2 mm in the left main
stem and less than 1 mm in other
major coronary arteries
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vessels < 500 μm in diameter, and may cause MI. It is particu-
larly seen in hypertrophic and dilated hearts, preferentially in
the subendocardial areas of the myocardium. SVD is also a
common feature in diabetic hearts and hearts of patients with
longstanding hypertension, but structural changes such as some
vascular wall thickening, if present, are difficult to interpret in
practice and subject to interpretation bias. More rarely, structur-
al diseases of intramyocardial vessels may be identifiable which
include vasculitis, amyloidosis, small vessel type fibromuscular
dysplasia, of which the latter can be isolated or in association
with hypertrophic cardiomyopathy (HCM) or Fabry’s disease
[37–39]. It is important to note that in all these instances, myo-
cardial areas with reduced flow due to concomitant epicardial
(large vessel) coronary stenosis are most vulnerable. In
transplanted hearts, SVD can be caused by widespread small
vessel stenosis due to cardiac allograft vasculopathy [40].
Microvascular coronary embolization with thromboembolic
materials distal to a thrombosed epicardial plaque can be found
at autopsy in patients who died of MI [16, 39, 41] and occur
nowadays even more frequently in acute MI patients who are
treated with primary percutaneous coronary intervention (PCI)
for acutely thrombosed plaques. In clinical studies, such emboli
are an uncommon cause of acute MI, although they may result
in microinfarctions occurring scattered through the myocardi-
um. In later stages, they may leave small areas of replacement
fibrosis. Moreover, microvascular embolization can occur in
patients with atrial fibrillation, prosthetic heart valves, infective
endocarditis or cardiac myxoma.
Iatrogenic pathology of the coronary arteries
Progressive stenosis or acute thrombotic occlusion of a coro-
nary artery can be treated by means of PCI in order to prolong
life, to relieve symptoms, or minimizemyocardial necrosis. At
present, nearly all PCI procedures involve implantation of a
metal stent or more recently, bioresorbable scaffolds (BRS).
Stent-related complications, which are thrombosis and
fibrocellular restenosis, have reduced significantly over the
past years, mainly due to widespread application of drug-
eluting stents (DES) [42]. Acute stent thrombosis is very rare
and may occur due to stent malposition, dissection, long or
angulated stented segments, or sometimes due to hypersensi-
tivity reactions. Late stent thrombosis, occurring even more
than a year after placement, also remains a rare but life-
threatening complication in approximately 2% of patients
and is mostly due to impaired neointimal covering of the coat-
ed stent and withdrawal of anti-platelet therapy [42].
Moreover, fibrocellular restenosis remains a problem in the
still large group of patients, worldwide treated with non-
coated bare metal stents (BMS). A more recently described
long-term complication is the occurrence of in-stent
neoatherosclerosis. Stent-related pathologies are coronary
causes of the clinical type 4 MI. Autologous vein grafts or
mammary arteries, which are used for CABG procedures,
should also be examined carefully. A patent graft at autopsy
is normally an empty collapsed vessel. Acute graft thrombosis
can be due to technical failure at anastomosis sites, low left
ventricular output failure or poor run-off in the distal vascular
bed. Vein grafts may develop diffuse concentric intimal le-
sions within a few years, eventually complicated by thrombot-
ic occlusion. Mammary arteries are particularly resistant to the
development of intimal hyperplasia or neoatherosclerosis.
Both in cases of PCI or CABG-related MI (clinical types MI
4 and 5), application of post-mortem coronary angiography
should be considered. This method enables to localize stents,
to visualize the patency of stents and grafts, and to evaluate the
run off into the distal arterial bed and presence of collateral
vascularization. Histological sampling of the jeopardized
myocardium is crucial to investigate the presence of any form
of myocardial injury as will be discussed later.
Myocardial pathology in relation to ischemic death
Irreversible damage of cardiomyocytes is the hallmark of MI,
and results in ischemic necrosis, which is histologically
‘coagulative type’ necrosis. It should be discriminated from
another type of necrosis that can be found regularly at autopsy,
the ‘contraction band type’ of necrosis, which is a feature of
many other forms of myocardial injury. For completeness, it
should be mentioned that autophagy and apoptosis also occur
during myocardial injury, but they are of less significance for
daily practice, and will not further discussed.
Evolution of myocardial necrosis in prolonged ischemic
conditions
The onset of ischemic necrosis is not immediate. In animal
studies, using controlled occlusion of coronary arteries in
healthy hearts, irreversible myocardial ischemia can be detect-
ed after 20 min [43]. In humans at autopsy, in which pre-
existent (ischemic) diseased hearts are not uncommon, timing
is less certain. Ischemic necrosis of myocardial cells can be
detected reliably with the current diagnostic methods after
circa 2–4 h, but the onset depends on many variables such
as collateral circulation, ischemic preconditioning and micro-
vascular pathology. After the onset of occlusion, myocardial
necrosis evolves in a wave front-like pattern over several
hours from the endocardium to the epicardium [44, 45]. This
implies that the loss of viable myocardium in the ‘area at risk’
(perfusion area of the occluded artery) gradually increases,
finally ending up in a transmural MI. Therefore, in clinical
cardiology, it is of pivotal importance to open the occluded
artery by means of PCI or thrombolysis as early as possible,
and reduce the size of the MI or even prevent it (‘time is
muscle’). During the evolving wave of myocardial necrosis,
ventricular arrhythmias may occur in the subendocardium,
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even at the earliest stage of still reversibly damaged myocar-
dium, but also several hours after occlusion when the wave of
necrosis has evolved substantially. This is also important for
pathologists to realize: early onset arrhythmia and SCD will
reveal only early signs of myocardial injury or no changes at
all, whereas later on in the wave of developing myocardial
necrosis, a full-blown infarction can be visualized at histology.
It should also be noted that later stages of myocardial necrosis
and even old fibrotic scars can serve as a substrate for life-
threatening arrhythmias [46].
Topographic distribution of MI in the heart
According to the myocardial region involved, MI is classified
as either regional when it involves the perfusion area of one
epicardial artery, or circumferential when it encompasses the
largest part of the circumference of the ventricular wall.
Regional MI can be either transmural, usually associated with
ST segment elevations on ecg (STEMI), or only subendocar-
dial (non-STEMI). Early reperfusion interrupts the wave front
of necrosis, which limits irreversible damage to the subendo-
cardial region only (Fig. 2). The topography of segmental MI
corresponds grossly to the perfusion territory of the three large
epicardial arteries or, more rarely, one of their branches such
as the first diagonal branch or the obtuse marginal artery.
Occlusion of the left main stem usually results in immediate
death. However, in the presence of extensive collateral circu-
lation, which occurs frequently in chronically ischemic hearts,
the association between site/extent of necrosis and the occlud-
ed branch is often less obvious (‘paradoxical infarction’).
Application of post-mortem angiography to the excised heart
or during whole body post-mortem CT-angiography
(PMCTA) can provide important information on the presence
and extent of collaterals between the vascular beds of major
epicardial arteries (shown by a retrograde filling pattern), or
neovascularization around chronic total occlusions (‘bridging
collaterals’) (Fig. 3). Circumferential MI is mostly due to an
overall fall in coronary perfusion pressure, often in the pres-
ence of severe multivessel CAD and involves in many cases
only the subendocardial region.
Aberrant patterns of ischemic damage such as disseminated
or predominantly epicardial locations have been reported in
patients who died after resuscitation (see later) or in a setting
of septic shock. In the latter, ischemia likely results from
inflammation-related microvascular spasm, damage or throm-
botic occlusions [47].
Atrial infarctions occur in combination with ventricular
infarctions and have variable reported incidence among MI
patients ranging from 0.7 to 42%. Isolated atrial infarctions
are scarce. The leading cause of atrial MI is coronary athero-
sclerosis. Pathologic significance is obviously lower than in
ventricular infarctions, but for a pathologist, two potential
complications of atrial MI should be underlined. The first is
mural thrombus formation followed by thromboembolization,
mostly pulmonary emboli (> 80% of atrial infarctions are lo-
cated in right atrium), and the second, the rare cases of atrial
rupture that can result in cardiac tamponade [48].
Post-mortem diagnosis of MI: gross, enzymatic
and (immune) histological changes
Many attempts have been undertaken to identify irreversible
myocardial ischemia as accurately as possible and to discrim-
inate myocardial ischemia from other forms of myocardial
Fig. 2 Patterns of topographic







injury. Obviously, this information can be crucial in cases of
sudden death, natural or accidental, witnessed or unwitnessed
in forensic pathology, but also in case of deaths around the
time of therapeutic coronary interventions or other medical
investigations. Timing of the cellular events based on autopsy
observations in humans has been described in detail in old
original publications [49, 50] and also in textbooks of pathol-
ogy [51, 52]. They are summarized in Table 4 and illustrated
in Fig. 4. However, when applying the listed histological pa-
rameters to estimate the age of MI, it should be noted that
many of them overlap, and, most importantly, they are subject
to many factors that could affect the timing (Table 5). These
factors include the age of the patient, the size of the infarction,
ongoing inflammatory diseases and disorders of immunity;
and local cardiac factors, including collateral circulation, is-
chemic pre-conditioning, repeated ischemic insults and reper-
fusion of the ischemic area. Changes occurring during cardio-
pulmonary resuscitation (CPR) and autolysis can mimic the
early histologic changes of MI [5]. Therefore, more reliable
clinic-pathological correlations can be drawn at autopsy by
aiming to discriminate between four stages of injury and repair
that relate to important clinical scenarios of ischemic morbid-
ity and death. These four stages are:
1. Earliest stage of cell death (first hours): transmission elec-
tron microscopy (TEM) reveals very early ischemic
changes such as mitochondrial swelling and sarcolemmal
disruptions in cardiomyocytes occurring already 10min after
Table 4 Histologic parameters of tissue damage and repair overtime in myocardial infarction (without reperfusion); see text for references
Myocardial histologic parameters
(HE staining)
Earliest manifestation Full development Decrease/disappearance
Streched/wavy fibres 1–2 h
Coagulative necrosis: ‘hypereosinophilia’ 1–3 h 1–3 days; hyper-eosinophilia and loss of
striations
> 3 days: disintegration
Interstitial oedema 4–12 h
Coagulative necrosis: ‘nuclear changes’ 12–24 (pyknosis, karyorrhexis) 1–3 days (loss of nuclei) Depends on size of infarction
PMN infiltration 12–24 h 1–3 days 5–7 days
PMN karyorrhexis 1.5–2 days 3–5 days
Macrophages and lymphocytes 3–5 days 5–10 days (including ‘siderophages’) 10 days to 2 months
Vessel/endothelial sprouts* 5–10 days 10 days–4 weeks 4 weeks: disappearance
of capillaries; some large
dilated vessels persist
Fibroblast and young collagen* 5–10 days 2–4 weeks After 4 weeks; depends on
size of infarction;
Dense fibrosis 4 weeks 2–3 months No
*Some authors summarize the vascular and early fibrotic changes as ‘granulation tissue’, which is maximal at 2–3 weeks
Fig. 3 Visualization of coronary
collaterals in post-mortem
angiograms. Contrast filling of
right coronary artery (RCA)
shows retrograde filling through
collaterals of a large marginal
branch of occluded left coronary
artery (a). Contrast filling of RCA
of another heart shows extensive
‘bridging collaterals’ surrounding
a chronic total occlusion of the
artery (b)
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onset. However, this method can only be used in experimen-
tal conditions [53] and is not useful to detect early human
ischemia because of the similarities between early ischemic
changes and autolysis. Earliest lightmicroscopic changes are
a regional wavy pattern of myocytes as a result of stretching
of dead non-contractile myocytes by adjacent functional
myocardium during the cardiac cycle [50]. In the first hours,
interstitial oedema and early onset of coagulative necrosis
shown by cytoplasmic hyper eosinophilia also appear.
However, these changes may have poor reliability in some
instances and are subject to over-interpretation.
2. Inflammatory stage (first week): infiltration of neutrophils
begins at MI borders. Neutrophils can also invade the
central area of a small MI, but this happens much later
Fig. 4 Histological features ofMI
at different stages, without
reperfusion; myofiber waviness






and lymphocyte infiltration with
early removal of necrotic debris
(e); granulation tissue with
formation of microvessels (f);
fibroblast proliferation and early
collagen deposition (g); dense
fibrous scar replacing myocyte
loss (h). All sections are stained
with haematoxylin and eosin
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depending on the size of the infarction. Coagulation ne-
crosis proceeds by showing the changes of further nuclear
and myocyte disintegration. This coincides with heavy
interstitial infiltrates of neutrophils and karyorrhexis of
the neutrophils. Macroscopically, it acquires grey-
yellowish colour. At this stage, necrotic myocardium is
weak and vulnerable to septal, papillary muscle or free
wall ruptures in case of transmural infarctions, all with
high mortality. Early phagocytosis of dead cells by mac-
rophages, infiltration of other mononuclear cells such as
lymphocytes and onset of a marginal fibrovascular re-
sponse highlight further continuation of the healing pro-
cess. However, in large MIs, residual necrotic areas can
still be detected even after many weeks.
3. Granulation tissue stage (1 week to several weeks): this
stage features capillary sprouting and ingrowth of fibro-
blasts with initial deposition of loosely arranged collagen
fibres, and a persistent inflammatory infiltrate of lympho-
cytes, sparse plasma cells, macrophages including
siderophages, whereas the number of neutrophils de-
creases. Granulation tissue ismost abundant at 2–3 weeks.
Grossly, this can be seen as a gelatinous hyperaemic bor-
der around the necrosis.
4. Late fibrotic (scarring) stage (beyond several weeks): the
granulation tissue disappears gradually and is replaced by
dense collagen leading to fibrotic scars, which usually
contains dilated thin-walled vessels. The rate of disap-
pearance of granulation tissue depends on the size of the
MI but is completed by the second month in most in-
stances, leaving a hypocellular compact scar.
Enzymatic detection of early necrosis in fresh myocardium
Nitro blue tetrazolium (NBT) staining of a fresh myocardial
slice demonstrates early ischemic necrosis and is reported to
be positive from 3 h after onset of ischemia. NBT stains only
in the presence of intracellular lactate dehydrogenase (LDH).
Leakage of enzymes from irreversibly injured myocardium
appears as an unstained area in the otherwise deep purple
stained vital myocardium [50, 51] [5] (Fig. 5). Unstained
areas are not fully specific for MI, but can be caused also
by other forms of injury although usually not in a distinct
regional pattern. In addition, NBT staining is reported to be
somewhat vulnerable to artefacts with false positivity in case
of technical failure (inappropriate temperature or incubation
time, formalin contamination), or situations like sepsis, CPR
or long post-mortem intervals.
Table 5 Diagnostic pitfalls in post-mortem diagnosis of myocardial ischemia
Diagnostic method Finding Possible pitfalls
Histological
examination
Contraction bands Marker for ischemia/reperfusion (including border zones of ischemic infarctions), and
other types of myocardial injury
Histopathological timing of
ischemia/infarction
Evolution may be affected by several variables (individual heterogeneity in the response
to injury, repair and inflammatory response, size of infarction and medications that
affect inflammation and wound healing, collateral circulation)
Resuscitation trauma and autolysis can mimic histologic features of early MI (false
positivity).
Immunohistochemistry Some antibodies may have low
sensitivity/specificity for early
ischemic necrosis
Stains also other forms of myocardial injury; influenced by autolysis and post-mortem
interval; probably early detection, but exact time of onset of immunopositivity not
exactly known
Can occur in cases with long post-mortem interval
Nitro blue tetrazolium
(NBT) staining
Diffuse or spotty discoloration Unstained areas can occur in cases of long post-mortem interval, resuscitation attempts,
sepsis, technical failures (see text)
Post-mortem imaging Calcifications in PMCT Heavily calcified coronaries can be observed in stable plaques, not necessarily related to
acute coronary syndromes and MI
Non-calcified coronaries or spotty calcifications of coronaries might be observed in
eroded plaques
Perfusion of coronaries in PMCTA Difficult to discriminate thrombus from post-mortem clot
Some thrombosed coronary arteries (eroded plaques) might be perfused (mural thrombi)
Difficult to evaluate the perfusion of heavily calcified coronaries
Interstitial oedema in PMMR Also positive in other forms of injury, including CPR, and may occur as post-mortem
alteration
Increased enhancement in PMCTA Can be influenced by resuscitation and post-mortem alteration
Cardiac biomarkers Increased of hs-TnT in serum Serum value can be influenced by post-mortem alteration
Cut-off of vital myocardial injury unknown
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Immunohistochemistry of myocardium
Several immunohistochemical markers have been investigat-
ed for the diagnosis of early MI, mostly markers for proteins
that accumulate (such as fibronectin and C5b-9) or leak out of
(such as troponins, myoglobin, S100A1) cardiomyocytes fol-
lowing ischemia. Other protein markers have been shown to
undergo early changes in their phosphorylation state, as is
demonstrated for connexin 43 [54, 55]. Markers/mediators
of early inflammation (CD15, IL-6, TNF-α, IL-15, IL-8,
CD18 and tryptase) have also been proposed [56]. Some of
them are promising in terms of early expression and specific-
ity (dephosphorylated connexin 43), but they have been main-
ly investigated in experimental models [55]. When tested in
human post-mortem samples, these markers keep their early
expression profile, but lose their specificity [4]. Therefore,
further investigations are needed before their eventual intro-
duction in routine. Moreover, several pathologic or iatrogenic
states such as CPR (including injection of catecholamines),
autolysis, pre-existing ischemic events and medical treatments
[4, 55] may influence the staining pattern and can interfere
with a diagnosis of ischemic injury. Currently, a diagnosis of
early myocardial injury in absence of changes in H&E stains
could be based on a combination of fibronectin and C5b-9
immune stains (Fig. 6). C5b-9 staining is more sensitive and
specific than fibronectin staining, but fibronectin positivity
starts earlier than C5b-9 [55]. In most cardiac transplant cen-
tres, C4d immunostaining is used routinely to detect myocar-
dial injury on paraffin sections but the exact timing is un-
known (Fig. 6). A larger panel of markers, simultaneously
detected in the same tissue section (multiplexing), and quan-
tification of their expression could improve the diagnostics of
early myocardial ischemia, as has recently been shown by
employing mass spectrometry immunohistochemistry [57].
Ischemia and reperfusion and other forms of injury
Myocardial and microvascular pathology after coronary inter-
vention are closely related and the most important manifesta-
tions are peri-procedural ischemia, myocardial reperfusion in-
jury and no-reflow phenomena, in combination with pre-
existent ischemic pathology of the myocardial area at risk
[58].
Contraction band necrosis (CBN) of myocytes is the earli-
est sign of myocardial injury, which arises circa 10 min after
onset of ischemia and reperfusion, and is characterized by the
occurrence of thick eosinophilic bands in the cytoplasm of
cardiomyocytes due to clustering of hypercontracted contrac-
tile proteins (Fig. 7a). After restoration of flow (reperfusion),
dying cardiomyocytes with ischemically damaged cell mem-
branes are exposed to high serum Ca2+concentrations, leading
to mass ive Ca2+ inf lux fol lowed by ir revers ib le
hypercontraction (CBN). It is important to note that contrac-
tion bands are not a feature of ischemic infarction alone, but
still, they occur frequently in the periphery (the ‘borderzones’)
of ischemic infarctions, which is due to microvascular collat-
eral perfusion from adjacent vital myocardium. Caution
should also be taken with the interpretation of presence of
CBN, since they can also be observed after CPR including
defibrillation and other trauma. Not specifically related to
PCI, but clearly of importance in a forensic setting, CBN has
been observed in situations of catecholamine excess, drown-
ing, drug abuse, cobalt poisoning, starvation, free radical in-
juries, brain death and intracerebral haemorrhage [59]. CBN is
accompanied by microvascular injury leading to endothelial
swelling, microvascular obstruction and interstitial
haemorrhages (Fig. 7b, c). Influx of granulocytes is usually
more pronounced when compared with non-reperfused MI,
since granulocytes invade throughout the reperfused area.
‘No-reflow’ is a clinically defined feature entailing absence
of tissue perfusion despite epicardial coronary patency and
flow after PCI or CABG. It is due to microvascular damage,
endothelial swelling, platelet plugging and spasm. In addition,
distal embolization of fragile thrombus fragments and lipid
Fig. 5 Nitro blue tetrazolium (NBT)-stained myocardium; myocardial
slice (middle) with circumferential subendocardial infarction indicated
by loss of staining (pale area); purple-stained tissue represents vital
myocardium, heart and apical slice are not NBT treated
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debris from the site of PCI may contribute to no-reflow of
even microinfarctions. Recent investigations also suggest a
role for embolization of the hydrophilic coating of guidewires
used during PCI procedures such as stent implantation. At
autopsy, such emboli are observed in myocardium distal to
the site of PCI-treated culprit lesions, and in the longer term
can be surrounded by inflammatory cells including foreign
body giant cells (Fig. 7d) [60].
MI in relation to hypertrophy and dilatation
of the heart
Myocardial oxygen consumption is proportional to ventricular
muscle mass, wall stress, heart rate and contractility. In hyper-
trophic and dilated hearts, and especially in combination with
coronary stenosis, tachycardia may significantly contribute to
symptoms such as effort type of angina or even sudden death.
At autopsy, any circumstances of death that may have pro-
voked tachycardia are informative [61]. The relationship be-
tween myocardial mass and oxygen demand is linear, so a
doubling in mass doubles oxygen demand. In athletes, the
adaptive changes in the heart ensure that the balance between
oxygen supply and demand is maintained [62]. However, in
pathological conditions such as hypertension, aortic stenosis
and cardiomyopathy, oxygen consumption increases out of
proportion to supply. According to the Laplace equation, ven-
tricular wall stress is proportional to chamber pressure and
radius, and inversely proportional to wall thickness. Dilated
hearts with volume overload (large chamber, thin ventricular
wall) may display substantially increased wall stresses, which
require high coronary perfusion gradients for optimal oxygen-
ation [61]. In situations of increased demand, usually during
exercise, this may evolve to myocardial ischemia, which is
preferentially located in subendocardial layers, where
microvascularization is less plentiful. Obviously, this situation
worsens in combination with stenosis of epicardial coronary
arteries by plaques that are frequently present in these patients
[61]. In dilated cardiomyopathies (DCM), imaging studies
using positron emission tomography (PET) have demonstrat-
ed this loss of myocardial blood flow reserve with changes
indicating ischemia [63]. Chronic ischemia is thought to un-
derlie the cytoplasmic clearing of subendocardial myocytes,
often seen in dilated hearts and around old infarctions, which
represents dysfunctional but still viable myocardium.
Circumferential subendocardial infarctions can be observed
regularly in the elderly population who died of hypertrophic
or dilated hearts due to aortic valve stenosis (Fig. 5).
Takotsubo syndrome
Takotsubo syndrome (TTS) is a clinical syndrome in the spec-
trum of ischemic heart disease that is characterized by acute
heart failure with transient regional myocardial wall motion
abnormalities in the absence of culprit atherosclerotic CAD.
Since the heart stands still after death, the typical shape of the
heart that is observed during systole in Takotsubo syndrome
cannot be detected after death. It is found in 1–2% of patients
presenting with suspected MI, mostly post-menopausal
Fig. 6 Immunostaining of early
myocardial infarction. Positive
staining for fibronectin (a) and
C5b-9 (b) in irreversibly injured
cardiomyocytes. Scale bars =
50 μm. Courtesy from Aljakna
et al., Int J Legal Med, 2018;
acute myocardial infarction in
papillary muscle immunostained
with C4d antibody (brown). Low
power view, bar = 0.25 mm,
highlights exact delineation of
necrotic areas (geographic zones,
and multifocal cells) (c); Higher
magnification, bar = 50 μm,
shows abrupt border between
vital tissue and necrotic area (d)
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women. In these patients, there is only a small elevation in
troponin levels, not enough for the diagnosis of MI. The syn-
drome is frequently preceded by a stressful emotional or phys-
ical trigger or can be secondary to an underlying disease such
as pheochromocytoma [64]. The cardiotoxic effects of high
levels of catecholamines play a central role in the pathophys-
iology, but SVD and CAS may also contribute. Recently, it
was suggested that autonomic-limbic dysfunction might play
a crucial role in the pathophysiology of TTS [65]. The histo-
pathology of TTS shows CBN and vacuolation of
cardiomyocytes with widened interstitial space in the acute
phase and recovery during follow-up. Individual cardiomyo-
cyte cell death, macrophage reaction and scarring have also
been described, predominantly in cases with an underlying
pheochromocytoma with prolonged catecholamine effect [66].
Resuscitation
Subendocardial infarction is common following cardiac arrest
and CPR with survival. Even when ventricular fibrillation
occurs very early after the onset of ischemia, infarction be-
comes visible at autopsy because of life support long enough
for structural myocardial changes to develop. When such pa-
tients eventually die with hypoxic brain damage or poor car-
diac function, the infarct can be first noted in the
subendocardium as irregular hemorrhagic areas due to reper-
fusion injury (Fig. 7c). In advanced cases, the whole circum-
ference of the LV shows diffuse hemorrhagic infarction.
Haemorrhage can obscure other features such as CBN and
coagulative necrosis of the myocytes. Attention should be
paid as the changes can sometimes be subtle and focal in the
papillary muscle and trabeculae of the LVand rarely occur in
the RV [67, 68]. Macroscopic and microscopic signs of myo-
cardial contusion following CPR (epicardial haemorrhage,
patchy necrosis, blood blisters, oedema) have also been re-
ported at autopsy without vital reaction [69]. Apart from ab-
errant location (epicardially, patchy, right ventricle), it can be
difficult to discriminate these signs from ischemia and reper-
fusion due to infarction as described above.
In situ post-mortem imaging of the heart
Radiological post-mortem examination of ischemic heart
permits the evaluation of morphological features of coro-
nary arteries and myocardium, but without the possibility
to perform functional radiological evaluation, as can be
applied in vivo. These new methods can be a useful ad-
junct to autopsy, allowing a detailed documentation of the
body before the dissection (of crucial importance for post-
surgery forensic cases), and to direct to sites of tissue
sampling. Some investigators suggest that post-mortem
imaging and especially minimal invasive autopsy can
even replace autopsy in case of a suspected MI [6, 70],
but there are still limitations and controversies about its
use in these situations [6, 7, 70–72]. In clinical practice,
coronary artery calcium score represents an independent
predictor of CAD events that correlates closely with over-
all atherosclerotic burden. Coronary calcifications are
Fig. 7 Histological features ofMI
with reperfusion; Detail of
myocardium with contraction
band necrosis (a); microvascular
damage and extravasation of
erythrocytes (b); macroscopic
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easily detectable by post-mortem computer tomography
(PMCT) but their detection is not sufficient to attribute
the death to myocardial ischemia. Thrombotic occlusions,
especially on eroded plaques, can occur also on non-
calcified plaques. Angiographic post-mortem methods en-
able evaluation of coronary artery lumen, detecting steno-
sis and suspected occlusions [70, 73]. Pre-stenotic dilata-
tion, called napkin-ring sign, was recently described and
considered to be the imaging correlate of a high-risk
plaque. This sign was reported to possess a high predic-
tive value for future cardiac events and was described in
post-mortem cases although its diagnostic value is un-
known [74]. PMCTA was shown as not a perfect replace-
ment for the histological examination [73]. Radiological
methods do not enable the certain differentiation between
vital thrombus and post-mortem clot.
The interpretation of oedema in MI during life is con-
sidered as complicated and controversial today. An initial
wave of oedema appears abruptly at reperfusion, signifi-
cantly attenuated by 24 h and then followed by a second
healing-related wave of oedema several days after reper-
fusion [75]. Post-mortem radiological evaluation of ische-
mic myocardium is extremely challenging. Multiphase CT
angiography (MPMCTA) has been suggested to be able to
detect infarcted areas as regions of pathological
enhancement of the signal. This technique can be instru-
mental to identifying affected regions for histological
sampling as is applied in minimally invasive autopsies
[76]. It was suggested that post-mortem MR (PMMR)
enables the detection of MI in situ and the estimation of
infarct age based on signal behaviour [77, 78] and a com-
bination of PMMR with heart biopsies was shown to have
high sensitivity and specificity for the detection of MI [7].
At this time, there is still a need to validate these novels
post-mortem imaging techniques by comparing them with
autopsy findings on patients who died of ACS (see also
Table 5).
Post-mortem cardiac biomarkers
Cardiac troponins (cTns) are the most frequently used bio-
markers in clinical practice as they are most sensitive and
specific for diagnosing cardiomyocyte injury [9, 79]. In recent
years, cTn measurement was replaced by the high-sensitivity
cardiac troponin T (hs-TnT) assay, able to detectMI within 3 h
after the onset [79, 80]. However, the increased levels of hs-
TnT indicate presence of myocardial injury and are not spe-
cific for ischemia [80]. Therefore, the technique is of limited
value to establish the exact cause of (cardiac) death. Serum
levels do not show any correlation with any cause of death
although low hs-TnT levels in pericardial fluid allow the ex-
clusion of the heart damage [81]. A non-linear significant
association between hs-TnT serum values and the presence
of IHD as the cause of death was suggested, but a cut-off value
as applies for in vivo could not be established, probably be-
cause of post-mortem alterations (Table 5). [82].
Conclusions
Clinical diagnosis of MI follows closely the new insights
in pathophysiology derived from recent progresses in car-
diac imaging, electrophysiology, biochemistry and coro-
nary intervention. Pathologists should be aware of these
insights in order to interpret their findings at autopsy ap-
propriately. In most cases, the currently available diagnos-
tic tools at autopsy appear appropriate for this purpose,
but pitfalls in diagnosis should be considered (Table 5).
Promising areas of investigation to increase diagnostic
yield at autopsy are the new tissue markers of acute tissue
injury (and reperfusion) and also whole-body post-
mortem imaging which is suggested to detect oedema as
an early marker of myocardial injury, and can be instru-
mental in guiding minimally invasive autopsy techniques.
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